宁波健世科技股份有限公司
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Jenscare released its multi-product portfolio's, including LuX-Valve Plus TRINITY study, JensClip and Ken-Valve, remarkable clinical outcomes at TCT 2025 in the U.S. 2025-10-30 09:00
LuX-Valve Plus Approved for Hong Kong-Macao Medicine and Equipment Connect 2025-10-09 21:00
Jenscare, releases 2025H1 interim results 2025-09-01 13:00
Jenscare Announces 2025H1 Interim Results 2025-09-01 09:00
Jenscare released 30-day follow-up results of LuX-Valve Plus TRINITY study and 1-year follow-up results of JensClip TMVr at EuroPCR 2025 2025-06-03 09:00
The 1-Year Follow-up Results of LuX-Valve Plus were Officially Released at TCT 2024 2024-11-01 21:00
The One-Year Outcome of LuX-Valve Plus TRAVEL II Study was Officially Released at TCT 2024 2024-10-31 21:00
Jenscare, with innovative TTVR, releases 2024H1 interim results 2024-08-28 21:00
Jenscare, with innovative TTVR, releases 2024H1 interim results 2024-08-28 09:00
1